FT516-102:APhase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjectswith Advanced Solid Tumors

Project: Research project

Project Details

Description

FT516-102:A Phase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjects with Advanced Solid Tumors
StatusActive
Effective start/end date2/20/202/29/24

Funding

  • Fate Therapeutics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.